Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation (Q24311603)

GOA release 2020-03-11

DNA demethylation

1 reference

GOA release 2020-03-11

author name string

Lulu Hu

1

0 references

Ze Li

2

0 references

Jingdong Cheng

3

0 references

Qinhui Rao

4

0 references

Wei Gong

5

0 references

Mengjie Liu

6

0 references

Yujiang Geno Shi

7

0 references

Jiayu Zhu

8

0 references

Ping Wang

9

0 references

Yanhui Xu

Damage detection and base flipping in direct DNA alkylation repair

10

0 references

language of work or name

English

0 references

publication date

19 December 2013

0 references

published in

Cell

0 references

volume

155

0 references

page(s)

1545-55

0 references

issue

7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET family proteins and their role in stem cell differentiation and transformation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

DNA methylation: TET proteins-guardians of CpG islands?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Landscape of TET2 mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Crystal structures of catalytic complexes of the oxidative DNA/RNA repair enzyme AlkB

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Crystal structures of DNA/RNA repair enzymes AlkB and ABH2 bound to dsDNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Crystal structure of the FTO protein reveals basis for its substrate specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Uncovering the role of 5-hydroxymethylcytosine in the epigenome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Repairing DNA-methylation damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TETonic shift: biological roles of TET proteins in DNA demethylation and transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

JBP1 and JBP2 are two distinct thymidine hydroxylases involved in J biosynthesis in genomic DNA of African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Dali server: conservation mapping in 3D

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

DNA methylation patterns and epigenetic memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

PHENIX: building new software for automated crystallographic structure determination

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Coot: model-building tools for molecular graphics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Determination of macromolecular structures from anomalous diffraction of synchrotron radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

1 reference

7 January 2021

EUKARYOTIC CYTOSINE METHYLTRANSFERASES

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tet family proteins and 5-hydroxymethylcytosine in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2013.11.020

7 January 2021